Literature DB >> 32176307

The OX40 Axis is Associated with Both Systemic and Local Involvement in Atopic Dermatitis.

Julie Sophie Elsner, Michael Carlsson, Julie Kristine Stougaard, Uffe Nygaard, Matthias Buchner, Regina Fölster-Holst, Malene Hvid, Christian Vestergaard, Mette Deleuran, Bent Deleuran.   

Abstract

Atopic dermatitis (AD) is a chronic, or chronically relapsing, inflammatory skin disease associated with asthma and allergic rhinitis, and is dominated by Th2 cells. The co-stimulatory T-cell receptor OX40 and its ligand, OX40L, play a central role in the pathogenesis of AD, as their interactions are crucial for the generation of TH2 memory cells. Using enzyme-linked immunoassay (ELISA) and flow cytometry on blood samples from patients with AD and healthy volunteers, this study shows that the serum level of soluble (s) OX40 is decreased in patients with AD, and the expression of OX40 by activated skin-homing CD4+ T cells is increased. This study further shows, using immunofluorescence on skin biopsies, that OX40+ and OX40L+ cells are co-located within the dermis, indicating local activity of OX40/OX40L. Serum levels of sOX40 were associated with atopic diseases and, together, these results support that the OX40 system is important for chronic inflammation in AD skin.

Entities:  

Keywords:  OX40; OX40L; atopic dermatitis

Mesh:

Substances:

Year:  2020        PMID: 32176307      PMCID: PMC9128899          DOI: 10.2340/00015555-3452

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  21 in total

1.  T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells.

Authors:  Jun-ichi Kashiwakura; Hidenori Yokoi; Hirohisa Saito; Yoshimichi Okayama
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

2.  Atopic dermatitis.

Authors:  Thomas Bieber
Journal:  N Engl J Med       Date:  2008-04-03       Impact factor: 91.245

Review 3.  Control of immunity by the TNFR-related molecule OX40 (CD134).

Authors:  Michael Croft
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

4.  Technical advance: soluble OX40 molecule mimics regulatory T cell modulatory activity on FcεRI-dependent mast cell degranulation.

Authors:  Riccardo Sibilano; Giorgia Gri; Barbara Frossi; Claudio Tripodo; Ryo Suzuki; Juan Rivera; Andrew S MacDonald; Carlo E Pucillo
Journal:  J Leukoc Biol       Date:  2011-06-07       Impact factor: 4.962

5.  OX40 ligand: a potential costimulatory molecule in atopic asthma.

Authors:  Mohamed Nazmy Farres; Mohamed Kamel Sabry; Eman Elsayed Ahmed; Hossam Moustafa Elkady; Nesrine Aly Mohamed
Journal:  J Asthma       Date:  2014-03-11       Impact factor: 2.515

6.  Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation.

Authors:  Kei Ikeda; Hiroshi Nakajima; Kotaro Suzuki; Shin-ichiro Kagami; Koichi Hirose; Akira Suto; Yasushi Saito; Itsuo Iwamoto
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

Review 7.  New insights into atopic dermatitis.

Authors:  Donald Y M Leung; Mark Boguniewicz; Michael D Howell; Ichiro Nomura; Qutayba A Hamid
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

8.  Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis.

Authors:  Julie K Laustsen; Tue K Rasmussen; Kristian Stengaard-Pedersen; Kim Hørslev-Petersen; Merete L Hetland; Mikkel Østergaard; Peter Junker; Malene Hvid; Bent Deleuran
Journal:  Arthritis Res Ther       Date:  2014-10-30       Impact factor: 5.156

9.  Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis.

Authors:  Amanda C Foks; Gijs H M van Puijvelde; Ilze Bot; Mariette N D ter Borg; Kim L L Habets; Jason L Johnson; Hideo Yagita; Theo J C van Berkel; Johan Kuiper
Journal:  J Immunol       Date:  2013-09-25       Impact factor: 5.422

10.  A simple set of validation steps identifies and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patients.

Authors:  Tue W Kragstrup; Thomas Vorup-Jensen; Bent Deleuran; Malene Hvid
Journal:  Springerplus       Date:  2013-06-15
View more
  2 in total

Review 1.  Novel Targeted Biological Agents for the Treatment of Atopic Dermatitis.

Authors:  Nan Yang; Zeyu Chen; Xilin Zhang; Yuling Shi
Journal:  BioDrugs       Date:  2021-07-02       Impact factor: 5.807

2.  OX40 Expression in Eosinophils Aggravates OVA-Induced Eosinophilic Gastroenteritis.

Authors:  Longwei Xu; Dan Tian; Minsi Zhou; Jiuyue Ma; Guangyong Sun; Hua Jin; Mingyang Li; Dong Zhang; Jing Wu
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.